News Archives | Future Medicine India


Indira IVF expands to South India

Indira IVF has expanded its fertility healthcare services to South India, according to an official release.

FM News Network
Read More..

Samsung Bioepis’ trastuzumab biosimilar prequalified by WHO

Samsung Bioepis’s trastuzumab biosimilar has been prequalified by WHO.
The medication can now be procured by the United Nations agencies and for national tenders.

FM News Network

Researchers win CRC grant for data-driven health care research in India

A team of researchers from L V Prasad Eye Institute (LVPEI), IIM Ahmedabad and the Indian Institute of Public Health (IIPH), Hyderabad were selected for the Clinical/Public Health Research Center (CRC) grant, announced LVPEI in a statement.

FM News Network

Eurolife expands production of IV infusion bottles

urolife Healthcare announced to invest INR 100 crores for expanding its production capacity of closed intravenous infusion bottle.

FM News Network

Spinal muscular atrophy market to touch US$2.5bn in Asia-Pacific by 2028: GlobalData

The spinal muscular atrophy (SMA) market across five Asia-Pacific countries including Australia, China, India, Japan and South Korea is expected to grow at a compound annual growth rate of 23.3% from US$308.6m in 2018 to US$2.5bn in 2028, according to GlobalData, a UK based data analytics and consulting company.

FM News Network

Chemical hair straightening may heighten breast cancer risk by 30% in women

Women who frequently used chemical hair straighteners showed a 30% higher chance for developing breast cancer compared to those who did not use them, evidenced a recent National Institutes of Health (NIH) research.

FM News Network

Eris Lifesciences acquires trademark anti-diabetes drug Zomelis from Novartis for Indian market

Eris Lifesciences has announced that the company has acquired trademark for Novartis Ag’s anti-diabetic medication, Zomelis, for USD 13 million on 3rd December, 2019.

FM News Network